... Chemical Biology & Drug Design, 83: 306–316. ... The preliminary biological activity of all the target compounds against VEGFR-2, EGFR, AKT1, ALK1 and ABL1 were evaluated, and the anti-angiogenesis activities ex vivo of some compounds were also investigated. ... Chemistry. ...